IGC (IGC Pharma, Inc.) Company Total Assets

IGC (IGC Pharma) - company brandmark

The business model of IGC Pharma, Inc. (IGC) relies on the success of cannabinoid trials against Alzheimer's disease, leaving the company hostage to FDA decisions. Risks are amplified by a critical vulnerability stemming from a lack of diversification within neurology. A retrospective of share value on GURU.Markets shows total assets at 8.71, while operational resilience remains absent until regulatory approval is obtained for the developed drugs.

IGC (IGC Pharma Inc) Company Total Assets history from 07/04/2022 to 10/31/2026

Comprehensive metric breakdowns and analytics for igcinc.us (IGC)

- stock quotes and analyst forecast:
Share Price IGC Pharma|IGC - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization IGC|IGC - Total Company Value
- book capitalization data:
Accounting Value of a Share IGC Pharma|IGC - Book Capitalization|Market Cap to Net Assets Ratio igcinc.us|IGC - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital IGC Pharma, Inc.|IGC - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGC Pharma|IGC - Company Aggregate Debts|Debts to Book Capitalization Ratio IGC|IGC - Company Long-Term Debts|Company Short-Term Debts IGC Pharma|Intermediate Coverage Ratio igcinc.us
- net income and valuation multiples indicators:
IGC - Company Net Income
Fundamental valuation:IGC Pharma Inc IGC
Signature product of India Globalization Capital

This indicator determines the financial scale of the business by calculating the total volume of resources via a reverse return on assets (ROA) formula. By analyzing the total asset value, the investor assesses the ability of IGC Pharma, Inc. (IGC) to fund the development of bio-therapies to combat dementia and the risk of impairment of specific pharmaceutical assets should market conditions shift within the neurology segment.

Direct competitors

Total Business Assets INDV|COLL (Collegium Pharmaceutical, Inc.) - Company Total Assets|Company Total Assets Cronos Group Inc|Aggregate Company Assets Tweed (CGC)|HITI (Canna Cabana) - Aggregate Asset Value|Company Total Assets ACB (Aurora Cannabis Inc.)|ACHV - Cumulative Company Assets|SKYE - Aggregate Company Assets|Company Assets Anebulo Pharmaceuticals Inc|INCR (intercure.co) - Cumulative Company Assets|Nutriband - Aggregate Asset Value|NSRX (Nasus Pharma Ltd.) - Company Total Assets|MIRA Pharma - Total Asset Value of Company|Company Total Assets FLGC|Company Total Assets imcannabis.com (IMCC)|Aggregate Company Assets Adial Pharmaceuticals, Inc. ADIL|Aggregate Asset Value ARTL|ENSC - Aggregate Company Assets|Titan Pharmaceuticals (TTNP) - Cumulative Company Assets|GNLN: Company Total Assets|INM - Company Total Asset Base|AKAN (Akanda Corporation) - Company Total Assets|ENVB - Company Balance Sheet Assets|Company Total Assets BGXX|Cumulative Company Assets Hempacco Co Inc. HPCO